More Than Just Risk: Genetic Testing Is Shaping Breast Cancer Treatment

https://investor.myriad.com/news-releases/news-release-detail/11171/

Myriad Genetics and BioMarin Pharmaceutical Inc. Enter Into ...

Apr 6, 2011 ... BRAC Analysis® is a molecular diagnostic product developed by Myriad Genetics which analyzes the BRCA1 and BRCA2 genes to assess a woman's ...

https://myriad.com/gene-results/BRCA2/1/

BRCA2 Gene Mutation Risk Test - Myriad Genetics

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet ...

https://myriad.com/healthcare-professionals/disease.../ovarian-cancer/

Hereditary Ovarian Cancer | Myriad Genetics

Individuals who carry a mutation in either the BRCA1 or BRCA2 gene have a condition called Hereditary Breast and Ovarian Cancer (HBOC) syndrome, which is ...

https://myriad.com/genetic-tests/myrisk-hereditary-cancer-risk-test/

MyRisk ® Hereditary Cancer Test with RiskScore - Myriad Genetics

The MyRisk Test offers the industry's lowest reported VUS rates for BRCA1 and BRCA2 of 0.3% and 0.7%, respectively.⁷. Lifetime Classification Commitment.

https://investor.myriad.com/news-releases/news-release-detail/21051/

Myriad Submits sPMA for myChoice® CDx with Lynparza® in First ...

Feb 11, 2020 ... The myChoice CDx test comprises tumor sequencing of the BRCA1 ... Patients with certain characteristics such as a family history of the disease, ...

https://investor.myriad.com/news-releases/news-release-detail/21441/

American Society of Clinical Oncology Exclusively Cites myChoice ...

Aug 21, 2020 ... ... BRCA1 or BRCA2 genes and/or genomic instability – as determined by Myriad myChoice CDx – are recommended by ASCO for PARP inhibitor therapy.

https://myriad.com/.../the-importance-of-knowing-your-family-cancer-histo...

The Importance of Knowing Your Family Cancer History and Genetic ...

Nov 25, 2024 ... BRCA1 is one of several breast cancer susceptibility genes, the next most commonly known one is BRCA2. Mutations in either of these two genes ...

https://investor.myriad.com/news-releases/news-release-detail/21116/

Myriad Receives Reimbursement for the BRACAnalysis® Diagnostic ...

Male breast cancer. Tumor tissue profiling tests that suggest retention of BRCA1 or BRCA2 germline pathogenic mutation if cancer eligibility criteria for ...

https://myriad.com/patients-families/disease-info/ovarian-cancer/

Hereditary Ovarian Cancer | Myriad Genetics

Has had a previously identified BRCA1, BRCA2 or other gene mutation in the family. Using Hereditary Cancer Testing to Reduce Your Risk of Ovarian Cancer. If the ...

https://investor.myriad.com/news-releases/news-release-detail/11726/

Myriad to Present Eight Studies at 2014 San Antonio Breast Cancer ...

Dec 3, 2014 ... ... BRCA1/2 breast cancer. Presenter: Andrew Tutt. Date: Thursday, Dec. 11, 9:30 a.m. to 9:45 a.m. CT. Title: Poster P3-06-11: Homologous ...